Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Race Oncology Ltd. ( (AU:RAC) ) has provided an update.
Race Oncology Ltd has announced the application for quotation of 168,408 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective October 30, 2025. This move indicates the company’s efforts to enhance its market presence and potentially raise capital, which could impact its operational capabilities and stakeholder interests positively.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies. The company is primarily engaged in the research and development of innovative oncology treatments, aiming to address unmet medical needs in the cancer treatment market.
Average Trading Volume: 496,171
Technical Sentiment Signal: Buy
Current Market Cap: A$605.9M
Learn more about RAC stock on TipRanks’ Stock Analysis page.